“It is our responsibility, as the trusted leader in weight management, to support those interested in exploring if medications are right for them,” said CEO Sima Sistani said in a prepared statement late Monday.
Ozempic manufacturer Novo Nordisk says that it’s not a weight loss drug. It’s used to improve blood sugar in adults with type 2 diabetes, along with diet and exercise, but can also help patients lose some weight. If it’s not treated, obesity can lead to lifelong health problems, including high blood pressure, diabetes and depression.
The estimated annual medical cost of obesity in the U.S. was almost $173 billion in 2019 dollars, according to the CDC. Annual medical costs for adults who had obesity were $1,861 higher than medical costs for people with healthy weight.
Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: WSJhealth - 🏆 413. / 53 Weiterlesen »
Herkunft: WSJhealth - 🏆 413. / 53 Weiterlesen »
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »